Evidence map›Paper›PMID 34207086›Full record

ArticleBrain sciences2021

Microglia Morphological Changes in the Motor Cortex of hSOD1

Sara Migliarini, Silvia Scaricamazza, Cristiana Valle, Alberto Ferri, Massimo Pasqualetti, Elisabetta Ferraro

Open access · goldAbstract read
In one paragraph

Article in Brain sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Loss of Nuclear TDP-43 Impairs Lipid Metabolism in Microglia-Like Cells.bioRxiv : the preprint server for biology · 2025
    Article
  5. Review
  6. Review
  7. Ferritin is closely associated with microglia in amyotrophic lateral sclerosis.Journal of neuropathology and experimental neurology · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sara MigliariniDepartment of Biology, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0003-2741-269X
Silvia ScaricamazzaNational Research Council, Institute of Translational Pharmacology (IFT), 00133 Rome, Italy.
Cristiana ValleNational Research Council, Institute of Translational Pharmacology (IFT), 00133 Rome, Italy.ORCID 0000-0002-0914-6511
Alberto FerriNational Research Council, Institute of Translational Pharmacology (IFT), 00133 Rome, Italy.
Massimo PasqualettiDepartment of Biology, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0002-0844-8139
Elisabetta FerraroDepartment of Biology, University of Pisa, 56126 Pisa, Italy.
Istituto di Farmacologia Traslazionale · ITUniversity of Pisa · IT

Funding

Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica HyperALSParent Project Muscular Dystrophy Italy-2018 to E.F.Progetti di Ricerca di Ateneo-PRA-University of Pisa 2020_37- to E.F.
6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) is characterized by the progressive degeneration of spinal motor neurons as well as corticospinal (CSN) large pyramidal neurons within cortex layer V. An intense microglia immune response has been associated with both upper and lower motor neuron degeneration in ALS patients, whereas microgliosis occurrence in the motor cortex of hSOD1

Indexed as

amyotrophic lateral sclerosismetabolic reprogrammingmicrogliamotor cortexneuroimmunologySOD1G93A

Identifiers

PMID34207086
PMCPMC8234003
OpenAlexW3176378788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.